NCT06774027
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 Negative Breast Carcinoma, +10 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
Clinical trial condition
Explore clinical trials studying HR+ HER2 Breast Cancer. Study availability and eligibility vary by location and protocol.
NCT06774027